[Unexplained iron-deficiency due to Helicobacter pylori]
Annechien van Hove1, Rob P R Adang, Willi H M van Kuijk
1Maastricht Universitair Medisch Centrum, afd. Intensive Care, Maastricht, The Netherlands.
Nederlands Tijdschrift Voor Geneeskunde
|October 28, 2009
Summary
Iron-deficiency anemia, a common global issue, can be caused by Helicobacter pylori infection. Eradicating H. pylori can restore iron levels and improve hemoglobin in patients with unexplained iron deficiency.
Area of Science:
- Gastroenterology
- Hematology
- Infectious Diseases
Background:
- Iron-deficiency is a widespread nutritional deficiency globally.
- Chronic blood loss is a common cause in Western countries, but the source remains unidentified in up to 30% of patients.
- Routine investigations often fail to reveal the underlying cause of iron deficiency.
Observation:
- This study details three cases (two males, one female) presenting with fatigue and iron deficiency.
- Endoscopic examinations in these patients showed no abnormalities.
- Helicobacter pylori infection was identified as a potential primary cause for their iron deficiency.
Findings:
- Successful eradication of H. pylori led to sustained normalization of iron status and hemoglobin levels in all patients.
- The underlying mechanism linking H. pylori to iron deficiency requires further investigation.
- Eradication therapy resulted in significant clinical improvement in iron balance and status for these individuals.
Implications:
- Investigating H. pylori infection is recommended for patients with unexplained iron deficiency.
- H. pylori eradication may be a crucial therapeutic strategy for resolving iron deficiency in affected individuals.
- This highlights a potential link between a common bacterial infection and a prevalent nutritional disorder, impacting patient management strategies.
Related Concept Videos
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
Peptic Ulcer
Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the mucus...
Gastritis II: Pathophysiology
The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
Peptic Ulcer Disease II: Pathophysiology
Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...
Peptic Ulcer Disease II: Pathophysiology
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Peptic Ulcer Disease I: Introduction
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...

